Indegene Limited delivered a strong financial performance for the fiscal year ended March 31, 2026. The company achieved annual revenue of INR 35,105 million, marking a 23.6% year-on-year growth. This momentum continued into Q4 FY26, with quarterly revenue reaching INR 10,034 million. Key highlights include stable EBITDA margins, significant client expansion with 53 clients generating over $1 million in revenue, and deep integration of GenAI across its service offerings.
Annual Financial Highlights
For the fiscal year 2026, Indegene reported a revenue of INR 35,105 million, a significant increase of 23.6% YoY. The company maintained operational resilience, reporting an EBITDA margin of 19.4%. Strong cash generation was evidenced by an OCF/PAT ratio of 162%, reflecting the high quality of earnings for the year.
Fourth Quarter Momentum
The company sustained growth in Q4 FY26 (January–March 2026), with revenue from operations hitting INR 10,034 million. This represents a 32.8% YoY growth in INR terms. Quarterly EBITDA stood at INR 1,889 million, showing a 23.2% YoY increase. The company also improved its liquidity position, with cash reserves of INR 15,385 million and a net DSO of 63 days.
Strategic Growth and Client Expansion
Indegene expanded its customer base significantly throughout the year, ending with 91 active client relationships. Notably, the number of clients contributing over $1 million in annual revenue rose to 53, a 29.3% increase from the previous year. This expansion is supported by the company’s ‘land-and-expand’ strategy and deep domain expertise in the life sciences sector.
Advancing with GenAI
A core driver of Indegene’s recent success has been its early and strategic adoption of GenAI. By integrating AI-native platforms across its commercial, medical affairs, and regulatory operations, the company is re-engineering end-to-end processes for its clients. This transformation has led to industry-leading productivity, with revenue per employee rising to $74.7k, as the company increasingly moves toward outcome-based commercial models.
Dividend Announcement
Reflecting the company’s robust financial position and disciplined execution, the Board has recommended a final dividend of ₹2.25 per share, representing a 12.5% increase over the previous fiscal year. Indegene management remains confident in maintaining this growth trajectory as they move into FY27.
Source: BSE
